{
    "organizations": [],
    "uuid": "26d8924cdcab848aba853cb20cadddc3f3331860",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-reprocell-to-sign-regenerative-med/brief-reprocell-to-sign-regenerative-medical-products-related-license-agreements-idUSL4N1RF1CL",
    "ord_in_thread": 0,
    "title": "BRIEF-ReproCELL to sign regenerative medical products related license agreements",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2 (Reuters) - ReproCELL Inc\n* Says it will sign regenerative medical products related license agreements with a JV, MAGiQ Therapeutics Inc, which will be established by the co, Q Therapeutics, Inc and Mahendra Rao on April 6\nSource text in Japanese: goo.gl/D63Wdj\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-02T09:54:00.000+03:00",
    "crawled": "2018-04-02T20:43:46.052+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "reprocell",
        "inc",
        "say",
        "sign",
        "regenerative",
        "medical",
        "product",
        "related",
        "license",
        "agreement",
        "jv",
        "magiq",
        "therapeutic",
        "inc",
        "established",
        "co",
        "q",
        "therapeutic",
        "inc",
        "mahendra",
        "rao",
        "april",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}